Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities

Journal of the American Medical Directors Association

Volumn 14, Issue 6, 2013, Pages 429-432

  Patterson Burdsall, Deborah ^a,b   Flores, Hanzel C ^c   Krueger, Jill ^c   Garretson, Sandra ^a   Gorbien, Martin J ^d   Iacch, Amy ^a   Dobbs, Vicky ^a   Homa, Theodore ^a  

^a Formerly Affiliated with Lutheran Home Lutheran Life Community   (United States)

^b UNIVERSITY OF IOWA COLLEGE OF NURSING   (United States)

^c Symbria Rx Services   (United States)

^d RUSH UNIVERSITY   (United States)

Author keywords

Clostridium difficile risk factors; Elderly; ICD 9 diagnostic codes; Interdisciplinary planning; Long term care; LTC; LTC formulary development; LTCF; Medicare A; Medication management; Older adults; PPI; Proton pump inhibitors

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ANTICOAGULANT THERAPY; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ASSESSMENT; DRUG COST; DRUG INDICATION; DRUG USE; DUODENUM ULCER; FOLLOW UP; GASTRITIS; GASTROESOPHAGEAL REFLUX; HEALTH CARE POLICY; HEARTBURN; HOSPITAL DEPARTMENT; HUMAN; ICD-9; INFECTION RISK; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICARE; MEDICATION THERAPY MANAGEMENT; NURSING HOME; NURSING HOME PATIENT; PEPTIC ULCER; PRACTICE GUIDELINE; REFLUX ESOPHAGITIS; REHABILITATION PATIENT; UNITED STATES; ZOLLINGER ELLISON SYNDROME;

EID: 84878833438     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2013.01.021     Document Type: Article

References (32)

1. IMS Institute for Healthcare Informatics. The use of medications in the United States: Review of 2010. Available at: Accessed October 1, 2011. http://www.imshealth.com/imshealth/Global/Content/IMS%20Institute/Documents/IHII_UseOfMed_report%20.pdf.
2. Sachs G., Shin J., Howden C. The clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther 2006, 23:2-8.
3. Sheen E., Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci 2011, 56:931-950.
4. Thomson A., Sauve M., Kassam N., Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010, 16:2323-2330.
5. Vanderhoff B.T., Tahboub R.M. Proton pump inhibitors: An update. Am Fam Physician 2002, 66:273-280.
6. Lanza F.L., Chan F.K., Quigley E.M. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009, 104:728-738.
7. Heidelbaugh J.J., Goldberg K.L., Inadomi J.M. Erratum: Overutilization of proton pump inhibitors: A review of cost-effectiveness and risk in PPI. Am J Gastroenterol 2009, 104:1072.
8. Alsultan M.S., Mayet A.Y., Malhani A.A., et al. Pattern of intravenous proton pump inhibitors use in ICU and non-ICU setting: A prospective observational study. Saudi J Gastroenterol 2010, 16:275-279.
9. Andriulli A., Merla A., Bossa F., et al. How evidence-based are current guidelines for managing patients with peptic ulcer bleeding?. World J Gastrointest Surg 2010, 2:9-13.
10. Faulk C.E., Sandoval A., Draughon, et al. Critical gastrointestinal bleeding at an inpatient rehabilitation center: Incidence, risk factors, and the role of gastrointestinal prophylaxis. PM R 2010, 2:1104-1112.
11. Cunningham R., Dale B., Undy B., Gaunt N. Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea. J Hosp Infect 2003, 54:243-245.
12. Oertle M., Mouton W.G. Prescribing practice in a Swiss primary and secondary acute care hospital. Swiss Med Wkly 2006, 136:769-775.
13. Laria A., Zoli A., Gremese E., Ferraccioli G. Proton pump inhibitors in rheumatic diseases: Clinical practice, drug interactions, bone fractures and risk of infections. Reumatismo 2011, 63:5-10.
14. Teramura-Grönblad M., Hosia-Randell H., Muurinen S., Pitkala K. Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents. Scand J Prim Health Care 2010, 28:154-159.
15. Yang Y.X., Lewis J.D., Epstein S., Metz D.C. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006, 296:2947-2953.
16. Chen J., Yuan Y.C., Leontiadis G.I., Howden C.W. Recent safety concerns with proton pump inhibitors. J Clin Gastroenterol 2012, 46:93-114.
17. Chapman D.B., Rees C.J., Lippert D., et al. Adverse effects of long-term proton pump inhibitor use: A review for the otolaryngologist. J Voice 2011, 25:236-240.
18. Baker D.E. Current FDA-related drug information-approvals, submission, and important labeling changes for US marketed pharmaceuticals. Hospital Pharmacy 2012, 47:139-144.
19. Desilets A.R., Asal N.J., Dunican K.C. Considerations for the use of proton-pump inhibitors in older adults. Consult Pharm 2012, 27:114-120.
20. Semla TP, Beizer JL, Higbee MD. Geriatric Dosage Handbook. Hudson, OH: Lexi-Comp, 2009:1321-1323.
21. George C.J., Korc B., Ross J.S. Appropriate proton pump inhibitor use among older adults: A retrospective chart review. Am J Geriatr Pharmacother 2008, 6:249-254.
22. Medpac. 2011. CMS Office of the Actuary. Skilled Nursing Facility Services. Available at: Accessed March 1, 2012. http://www.medpac.gov/chapters/Mar11_Ch07.pdf.
23. Yachimski P.S., Farrell E.A., Hunt D.P., Reid A.E. Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: Effect of standardized guidelines on prescribing practice. Arch Intern Med 2010, 170:779-783.
24. Centers for Medicare and Medicaid Services, State Operations Manual, pp. 345-449, 519-560. Available at: Accessed March 1, 2012. http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/som107ap_pp_guidelines_ltcf.pdf.
25. Ito T., Jensen R.T. Association of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B 12, iron, and magnesium. Curr Gastroenterol Rep 2010, 12:448-457.
26. Gau J.T., Yang Y.X., Chen R., Kao T.C. Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf 2012, 21:553-559.
27. Ahrens D., Behrens G., Himmel W., et al. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int J Clin Pract 2012, 66:767-773.
28. Ahrens D., Chenot J.F., Behrens G., et al. Appropriateness of treatment recommendations for PPI in hospital discharge letters. Eur J Clin Pharmacol 2010, 66:1265-1271.
29. Ramirez E., Lei S.H., Borobia A.M., et al. Overuse of PPIs in patients at admission, during hospitalisation, and at discharge in a tertiary Spanish hospital. Curr Clin Pharmacol 2010, 5:288-297.
30. de Souto Barreto P., Lapeyre-Mestre M., Mathieu C., et al. Prevalence and associations of the use of proton-pump inhibitors in nursing homes: A cross-sectional study. J Am Med Dir Assoc 2013, 14. 10.1016/j.jamda.2012.10.018.
31. Teramura-Grönblad M., Bell J.S., Pöysti M.M., et al. Risk of death associated with use of PPIs in three cohorts of institutionalized older people in Finland. J Am Med Dir Assoc 2012, 13:488.e9-488.e13.
32. O'Sullivan D.P., O'Mahony D., Parsons C., et al. A prevalence study of potentially inappropriate prescribing in Irish long term care residents. Drugs Aging 2013, 30:39-49.